Skip to contentpdufa.bio

IPH5301

Page updated ·next FDA decision on the calendar ·Data as of Nov 19, 2026 12:24 AM ET

IPH5301 is an Innate Pharma SA program. Its next catalyst is a Readout in Mar 2027.

IPHA catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Innate Pharma SA (IPHA). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Mar 2027IPHA

Questions

When is IPH5301's next FDA decision or readout?

The next tracked catalyst for IPH5301 is a Readout in Mar 2027.

What happened at IPH5301's most recent FDA decision?

No FDA decision for IPH5301 is in our archive yet.

Who makes IPH5301?

Innate Pharma SA (IPHA).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings. Each FDA decision links its own page, which names its source or says plainly that it has none.